{
    "title": "AstraZeneca to buy Alexion for $39 bln to expand in immunology",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-9046253/AstraZeneca-buy-Alexion-39-bln-expand-immunology.html",
    "date": "2020-12-12",
    "keywords": [
        "deal",
        "alexion",
        "soriot",
        "vaccine",
        "company",
        "cash",
        "cancer",
        "astrazeneca",
        "covid19",
        "share",
        "price",
        "call",
        "elliott",
        "immunology",
        "research",
        "pfizer",
        "equity",
        "astrazenecas",
        "segment",
        "drug",
        "growth",
        "capital",
        "increase",
        "closure",
        "year",
        "fund",
        "transaction",
        "trial",
        "burger",
        "business",
        "bet",
        "raredisease",
        "week",
        "rollout",
        "shot",
        "britain",
        "use",
        "saturday",
        "worth",
        "reference",
        "friday",
        "opportunity",
        "development",
        "disease",
        "executive",
        "range",
        "hemoglobinuria",
        "pnh",
        "anaemia",
        "blood",
        "revenue",
        "version",
        "soliris",
        "ultomiris",
        "market",
        "potential",
        "firm",
        "quarter",
        "race",
        "partner",
        "biontech",
        "efficacy",
        "advance",
        "stock",
        "precursor",
        "scale",
        "issue",
        "purchase",
        "enhertu",
        "sankyo",
        "world",
        "patient",
        "competition",
        "bid",
        "target",
        "hedge",
        "investor",
        "management",
        "buyer",
        "ceo",
        "ludwig",
        "approach",
        "traction",
        "plan",
        "pipeline",
        "request",
        "comment",
        "core",
        "synergy",
        "completion",
        "analyst",
        "speculation",
        "way",
        "board",
        "result",
        "bidder",
        "finance",
        "chief",
        "marc",
        "dunoyer"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}